What are the precautions for the Sotolasib AMG510 produced by Ziska, Bangladesh?
Sotoracib (AMG510) is an anti-tumor drug. It is the first targeted drug to treat KRAS G12 mutations and is suitable for the treatment of adult patientsKRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer(NSCLC) has a significant effect in the treatment of lung cancer. What are the precautions for sotolasib produced in Ziska, Bangladesh?

Sotoraxib can cause hepatotoxicity, which may lead to drug-induced liver injury and hepatitis. atCodeBreaK Among 100of 357patients who receivedsutoracib, the incidence of hepatotoxicity was 1.7% (All levels)and 1.4% (Level 3). Alanine aminotransferase(ALT)/aspartate aminotransferase< /span>(AST)elevated; 6% is grade three, 0.6% is grade four. The median time to first onset of ALT/AST elevation was 9 weeks(< span>Range:0.3to42weeks). 7%of patients experienced ALT/AST elevations leading to dose interruption or reduction. 2.0%of patients discontinued sutrasibu due to ALT/AST elevations. In addition to dose interruption or reduction, 5%of patients received corticosteroids for treatment of hepatotoxicity. Monitor liver function tests (ALT, AST and total bilirubin every 3 weeks for 3 months before starting treatment),Then test patients with elevated transaminases or bilirubin at monthly intervals or more frequently as clinically indicated. Depending on the severity of the adverse reaction, discontinue, reduce dose, or permanently discontinue sotolaxibu.
Sotoraxibucan cause fatalILD/pneumonia. atCodeBreaK Of 100of 357patients who received sutoracib, 0.8% developed ILD/ Pneumonia, all cases were grade or grade 4 at the time of onset, and 1 case died. ILD/The median time to first onset of pneumonia is 2 weeks(< span>Range: 2 to 18weeks). 0.6%of patients discontinued sutrasibu due to ILD/pneumonitis. Monitor patients for new or worsening symptoms of ILD/pneumonia (such as difficulty breathing, cough, fever). In patients with suspected ILD/pneumonia, discontinue soteracib immediately and permanently if no other potential cause of ILD/pneumonia is identified. If you want to get more high-quality information, you can contact YaoDe. YaoDe will do its best to learn more about high-quality overseas drugs for you.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)